Moderna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccinesMarket Watch • 08/26/22
Pfizer And Moderna Are In A Race With Omicron; Will The Vaccine Stocks Be Too Late?Investors Business Daily • 08/26/22
Study finds Pfizer's antiviral has little or zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest weekMarket Watch • 08/25/22
Nate Silver: ‘Liberal elites' pressured Pfizer to delay vaccine until after 2020 electionNew York Post • 08/25/22
Pfizer announces positive data from Phase 3 trial of older adults for bivalent RSV vaccine candidateMarket Watch • 08/25/22
Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine CandidateBusiness Wire • 08/25/22
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorizationMarket Watch • 08/24/22
Pfizer and BioNTech say data shows COVID vaccine has more than 70% efficacy in small children, and cases now rising in just 7 statesMarket Watch • 08/23/22
Pfizer and BioNTech say COVID vaccine data showed 73.2% efficacy among children aged 6 month to 4 yearsMarket Watch • 08/23/22
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of AgeGlobeNewsWire • 08/23/22
Coronavirus tally: Pfizer and BioNTech formally apply for FDA nod for bivalent COVID booster for people aged 12 and olderMarket Watch • 08/23/22
Pfizer asks FDA to authorize Covid booster shots that target omicron BA.5 for people ages 12 and olderCNBC • 08/22/22
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 VaccineBusiness Wire • 08/22/22